From January 1, 2024 to March 31, 2024, the company has repurchased 10,434,700 shares, representing 0.94% for CNY 166.48 million. With this, the company has completed the repurchase of 10,546,300 shares, representing 0.95% for CNY 168.33 million under the buyback announced on December 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.43 CNY | +0.12% | +3.66% | -3.41% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.41% | 2.51B | |
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.19B | |
+3.98% | 3.15B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B | |
+39.87% | 1.45B |
- Stock Market
- Equities
- 603858 Stock
- News Shandong Buchang Pharmaceuticals Co., Ltd.
- Tranche Update on Shandong Buchang Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 14, 2023.